文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

浙江省45家医院重症监护病房对重症社区获得性肺炎糖皮质激素使用情况的调查

[Survey on the use of glucocorticoids in severe community-acquired pneumonia in intensive care unit of forty-five hospitals in Zhejiang Province].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论浙江省45家ICU调查显示,ICU医生对SCAP糖皮质激素应用指征的知晓率仅13.81%,使用异质性高,需加强指南学习并制定个体化方案。

该调查于2016年6月向浙江省二级以上医院ICU医生发放问卷340份,2个月内全部回收,有效问卷333份,来自45个ICU。结果显示,79.58%的医生阅读过CAP指南,但仅13.81%的医生了解糖皮质激素在SCAP中的临床应用指征;工作年限超过10年者阅读率93.07%,高于1-5年者的74.00%和6-10年者的73.17%(均P<0.05)。在严重病毒性肺炎中44.74%的医生常规使用糖皮质激素;选用甲泼尼龙者占79.58%,其中60.75%剂量≤80 mg/d,79.15%疗程≤7天。作者认为需加强ICU医生对国内外临床指南的学习,并根据患者具体情况制定糖皮质激素使用方案。

要点

  • 333名ICU医生中仅13.81%(46/333)了解糖皮质激素在SCAP中的临床应用指征,知晓率低。
  • 工作年限超过10年者指南阅读率93.07%(94/101),高于1-5年者的74.00%(111/150)和6-10年者的73.17%(60/82),均P<0.05。
  • 44.74%(149/333)的医生在严重病毒性肺炎中常规使用糖皮质激素,严重细菌性肺炎为22.82%(76/333),严重真菌性肺炎为9.31%(31/333)。
  • 选用甲泼尼龙的医生占79.58%(265/333),其中60.75%(161/265)处方剂量≤80 mg/d,79.15%(224/283)疗程≤7天。
  • 52.65%(149/283)的医生在入院24小时内使用糖皮质激素,47.35%(134/283)在入院1-7天使用。

适用人群与场景

  • 浙江省二级以上医院ICU医生,来自45个ICU,共333名有效问卷参与者。

处置流程与药物剂量

  • 79.58%(265/333)的医生选择甲泼尼龙,4.20%(14/333)选择氢化可的松,1.20%(4/333)选择地塞米松,15.02%(50/333)未使用糖皮质激素。
  • 选择甲泼尼龙的医生中,60.75%(161/265)处方剂量≤80 mg/d;79.15%(224/283)选择疗程≤7天。
  • 52.65%(149/283)的医生在入院24小时内使用糖皮质激素,47.35%(134/283)在入院1-7天使用。
  • 44.74%(149/333)的医生在严重病毒性肺炎中常规使用糖皮质激素;严重细菌性肺炎为22.82%(76/333),严重真菌性肺炎为9.31%(31/333),严重肺孢子菌肺炎为22.52%(75/333),慢性阻塞性肺疾病(COPD)合并严重肺炎为18.32%(61/333)。

研究设计与关键结果

  • 调查于2016年6月发放问卷340份,2个月内全部回收,有效问卷333份,来自浙江省45个ICU。
  • 79.58%(265/333)的医生阅读过CAP指南;工作年限超过10年者阅读率93.07%(94/101),高于1-5年者的74.00%(111/150)和6-10年者的73.17%(60/82),均P<0.05。
  • 研究生及以上学历者阅读率85.35%(134/157),高于本科者的74.43%(131/176),P<0.05。
  • 高级职称医生阅读率93.07%(94/101),高于初级职称者的71.43%(80/112)和中级职称者的75.83%(91/120),均P<0.05。
  • 了解糖皮质激素临床应用指征的医生比例为13.81%(46/333);工作年限超过10年者和高级职称者知晓率分别为23.76%(24/101)和20.79%(21/101)。
  • 不同学历和不同级别医院医生的知晓率无显著差异。
  • 入院24小时内使用糖皮质激素的比例在低学历医生和二级医院中更高:本科学历者为61.39%(97/158),二级医院为67.50%(27/40)。
  • 工作年限、学历、职称和医院等级对甲泼尼龙的选择及疗程无显著影响。

证据类型、等级与局限

  • 证据类型:问卷调查(横断面调查)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 调查显示ICU医生对SCAP糖皮质激素应用指征的知晓率仅13.81%,提示需加强ICU医生对国内外临床指南的学习。
  • 作者认为应根据患者具体情况制定糖皮质激素使用方案,使SCAP患者更多获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the use of glucocorticoids in patients with severe community-acquired pneumonia (SCAP) in the intensive care unit (ICU) of Hospitals in Zhejiang Province and to provide a reference for guiding clinical use of SCAP patients.

METHODS: To draw up a questionnaire with reference to the Chinese and international guidelines, and to investigate the knowledge of community-acquired pneumonia (CAP) related guidelines and the use of glucocorticoids in patients with SCAP by doctors in hospitals above secondary level in Zhejiang Province by Email. Then the valid questionnaire was analyzed.

RESULTS: In June 2016, 340 questionnaires were distributed, and all were returned after 2 months, with 333 of valid; 333 doctors from 45 ICUs in Zhejiang Province participated in the survey. (1) The knowledge of CAP-related guidelines in ICU doctors: 79.58% (265/333) of the doctors had read the CAP guidelines, and those who work over 10 years had a higher reading rate than those with 1-5 years and 6-10 years [93.07% (94/101) vs. 74.00% (111/150), 73.17% (60/82), both P < 0.05]. Post-graduates and above had higher reading rates than undergraduates [85.35% (134/157) vs. 74.43% (131/176), P < 0.05]. Senior doctors had higher reading rates than the junior and intermediate doctors [93.07% (94/101) vs. 71.43% (80/112), 75.83% (91/120), both P < 0.05]. The rate of understanding the clinical application of glucocorticoids was 13.81% (46/333). The doctors who work over 10 years and the seniorshad a relatively high awareness rate, 23.76% (24/101) and 20.79% (21/101) respectively. However, there was no significant difference in the awareness rate between doctors with different degrees and different levels of hospitals. (2) For the use of glucocorticoids in different causes of pneumonia, 44.74% (149/333) of doctors routinely used glucocorticoids in severe viral pneumonia. The proportion of glucocorticoids used in severe bacterial pneumonia, severe fungal pneumonia, severe pneumocystis pneumonia, chronic obstructive pulmonary disease (COPD) and severe pneumonia were 22.82% (76/333), 9.31% (31/333), 22.52% (75/333) and 18.32% (61/333), respectively. (3) The way of glucocorticoid usage: 79.58% (265/333) of doctors chose methylprednisolone, 4.20% (14/333) chose hydrocortisone, 1.20% (4/333) chose dexamethasone, and 15.02% (50/333) had not use glucocorticoids. The proportion of physicians who chose to use glucocorticoids within 24 hours of admission and 1-7 days after admission were 52.65% (149/283) and 47.35% (134/283), respectively. Glucocorticoids were used more in doctors with lower academic qualifications and hospitals within 24 hours. The undergraduate degree was 61.39% (97/158), and the second-grade class hospital was 67.50% (27/40). Among the doctors who chose methylprednisolone, 60.75% (161/265) prescribe the dose ≤ 80 mg/d; 79.15% (224/283) chose the course of ≤ 7 days. The number of years of work, education, professional title and hospital grade had no significant effect on the choice of methylprednisolone and the course of treatment.

CONCLUSIONS: ICU doctors of 45 hospitals in Zhejiang Province have a high degree of heterogeneity in the understanding of the use and guidelines of glucocorticoids in SCAP. It is necessary to strengthen the ICU doctor's study of clinical guidelines at home and abroad and to develop a glucocorticoid use plan according to the specific conditions of patients, so that SCAP patients can benefit more.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen G, Hu W, Xuan N, et al. [Survey on the use of glucocorticoids in severe community-acquired pneumonia in intensive care unit of forty-five hospitals in Zhejiang Province]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31109427. doi:10.3760/cma.j.issn.2095-4352.2019.04.023

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。